2 ASX shares to buy and hold for the next decade

I'm backing these ASX shares as long-term buys.

| More on:
Green arrow with green stock prices symbolising a rising share price.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Embracing a buy-and-hold strategy with ASX shares promotes compounding growth and reduces capital gains tax impact by minimizing asset sales.
  • TechnologyOne Ltd and VanEck MSCI International Quality ETF (ASX: QUAL) are highlighted as prime long-term investments due to their strong growth potential and quality-focused strategies.
  • Both investments are noted for impressive returns, with TechnologyOne aiming for significant revenue growth and the QUAL ETF achieving an average annual return of 15.75% over the past five years.

Buy-and-hold investing with ASX shares makes a lot of sense because it allows compounding to work its magic for a long period of time.

Lower turnover means fewer opportunities to lose some of the portfolio value to the ATO because of capital gains tax.

But, I'd only want to own great investments for a long time, not mediocre businesses. I'd expect strong companies to deliver better returns over time thanks to the above-average profit growth.

The two ideas below are high-quality ones that I've bought for my own portfolio and I'm excited about.

TechnologyOne Ltd (ASX: TNE)

The world is rapidly changing in some areas, including AI. Having the right technology for organisational operations is important, which is what TechnologyOne offers. It provides enterprise resource planning (ERP) software to governments, local councils, businesses and universities.

TechnologyOne invests around a quarter of its revenue each year into research and development (R&D), ensuring that it can continue to provide customers with the best (and improving) software. This initiative is also helping the ASX share unlock more revenue from subscribers as they pay for more features.

The company is aiming for a net revenue retention (NRR) of 115%, implying 15% growth of revenue from its existing customer base each year. At that pace, revenue would double in five years.

With the business targeting large addressable markets, such as the UK and education sector, I think it has a very attractive future. This ASX share is a great candidate for a buy and hold strategy. When also considering its rising dividend and growing profit margins, it's a very appealing investment.

According to the forecast on CMC Markets, the TechnologyOne share price is valued at 46x FY27's estimated earnings. In a decade, I'm expecting the company's annual recurring revenue (ARR) to be well over $1 billion.  

VanEck MSCI International Quality ETF (ASX: QUAL)

This is one of the exchange-traded funds (ETFs) that I'm putting my long-term retirement money into.

I'm a big believer that Australians should allocate a significant portion of their portfolio to international shares directly or indirectly because of how many great businesses are listed overseas.

But, we don't necessarily need to own a piece of thousands of companies, just the best ones. That's what the QUAL ETF is trying to provide – it owns 300 of the highest-quality global businesses from across various countries and sectors.

There are a few factors that all of the businesses inside of the QUAL ETF need to have. It's this combination of factors that makes them appealing.

Firstly, they must have a high return on equity (ROE). In other words, they make a high level of profit on how much shareholder funds are retained within the business.

Second, they have stable earnings. That means profits aren't going backwards – they're usually going upwards!

Finally, the companies must have low leverage. They should have low levels of debt for their size, making them more sustainable businesses. By utilising this quality-focused strategy, the QUAL ETF has managed to deliver an average return per year of 15.75% over the prior five years, outperforming many ASX shares in that time.

Motley Fool contributor Tristan Harrison has positions in Technology One and VanEck Msci International Quality ETF. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Technology One. The Motley Fool Australia has recommended Technology One. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Opinions

A business woman looks unhappy while she flies a red flag at her laptop.
Opinions

5 ASX shares I'm avoiding this week

There's warning bells ahead for these stocks.

Read more »

a hand reaches out with australian banknotes of various denominations fanned out.
Dividend Investing

These 2 ASX dividend shares are great buys right now

These defensive names look like strong picks today.

Read more »

Four piles of coins, each getting higher, with trees on them.
Growth Shares

2 ASX 200 shares that could be top buys for growth

These two businesses have an exciting future.

Read more »

Two IT professionals walk along a wall of mainframes in a data centre discussing various things
Technology Shares

This ASX 200 share is being labelled one of the market's most undervalued by brokers

NextDC shares have pulled back sharply, but brokers believe the long-term growth story remains firmly on track.

Read more »

Hand holding out coal in front of a coal mine.
Energy Shares

Up 25% in 2025: Is Whitehaven Coal still a buy?

After a strong 25% run this year, investors are asking whether Whitehaven Coal still has more upside left.

Read more »

Five guys in suits wearing brightly coloured masks, they are corporate superheroes.
Opinions

5 ASX shares I'd buy with $10,000 this week

These are the ASX stocks I have my eye on this week.

Read more »

bull market model with a bull looking at a rising chart
Opinions

By December 2026, $1,000 invested in EOS shares could be worth…

With its share price taking off and contracts piling up, EOS is shaping up as one of the most compelling…

Read more »

A doctor or medical expert in COVID protection adjusts her glasses, indicating growth or strong share price movement in ASX medical, biotech and health companies
Opinions

Forget CSL shares, I'd buy this booming biotech stock instead

This ASX biotech stock has caught my eye this year.

Read more »